Tectonic Therapeutics TECX EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Tectonic Therapeutics’s reported figures.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's EBITDA?
- Tectonic Therapeutics (TECX) reported EBITDA of -$27M in Q1 2026.
- How has Tectonic Therapeutics's EBITDA changed year-over-year?
- Tectonic Therapeutics's EBITDA decreased by 50.5% year-over-year, from -$17.94M to -$27M.
- What is the long-term trend for Tectonic Therapeutics's EBITDA?
- Over 4 years (2021 to 2025), Tectonic Therapeutics's EBITDA has grown at a -8.4% compound annual growth rate (CAGR), from -$117.44M to -$82.66M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.